| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/07/2011 | US20110165245 Compositions and methods for distraction osteogenesis |
| 07/07/2011 | US20110165231 Treatment of Fructose Malabsorption |
| 07/07/2011 | US20110165225 Modified Drugs for Use in Liposomal Nanoparticles |
| 07/07/2011 | US20110165215 Cohesive osteogenic putty and materials therefor |
| 07/07/2011 | US20110165200 Novel hydrogels and uses thereof |
| 07/07/2011 | US20110165199 Composition and Process for Bone Growth and Repair |
| 07/07/2011 | US20110165195 Composition for mucosal administration containing agent for enhancing mucosal absorption of peptide drug, and administration method thereof |
| 07/07/2011 | US20110165180 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
| 07/07/2011 | US20110165173 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for salusin |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165165 Mammalian genes; related reagents and methods |
| 07/07/2011 | US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant |
| 07/07/2011 | US20110165150 Isolated organ perfusion combination therapy of cancer |
| 07/07/2011 | US20110165149 Targeting abcb5 for cancer therapy |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | US20110165147 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 07/07/2011 | US20110165145 Igf-ii/igf-iie binding proteins |
| 07/07/2011 | US20110165144 Methods for treating rheumatoid arthritis |
| 07/07/2011 | US20110165143 Modulation of caspases and therapeutical applications |
| 07/07/2011 | US20110165142 Method of treating degenerative diseases |
| 07/07/2011 | US20110165141 Compositions for treating bacterial infections |
| 07/07/2011 | US20110165140 Dry Transglutaminase Composition |
| 07/07/2011 | US20110165139 Growth hormone secretion stimulator |
| 07/07/2011 | US20110165138 Protocols for treating and preventing obesity and complications arising therefrom |
| 07/07/2011 | US20110165137 Suppression of cancers |
| 07/07/2011 | US20110165136 Novel Herbal Composition for Treatment of Psoriasis and Other Skin Disorders |
| 07/07/2011 | US20110165135 Lactobacillus helveticus strains for producing hypotensive peptides |
| 07/07/2011 | US20110165132 Heparan Sulphate Which Binds BMP2 |
| 07/07/2011 | US20110165124 Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients |
| 07/07/2011 | US20110165123 5' triphosphate oligonucleotide with blunt end and uses thereof |
| 07/07/2011 | US20110165122 Method for targeted and sustained antiviral therapy |
| 07/07/2011 | US20110165121 Use of pegylated type iii interferons for the treatment of hepatitis c |
| 07/07/2011 | US20110165120 Inhibitors of serine proteases |
| 07/07/2011 | US20110165119 Telaprevir dosing regimen |
| 07/07/2011 | US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 07/07/2011 | US20110165117 Immunogenic peptides and methods of use |
| 07/07/2011 | US20110165116 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
| 07/07/2011 | US20110165112 Polymer conjugates of c-peptides |
| 07/07/2011 | US20110165111 Polymer conjugates of nesiritide peptides |
| 07/07/2011 | US20110165095 Composition and method for the inhibition of postoperative adhesions severity |
| 07/07/2011 | US20110165093 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/07/2011 | US20110165083 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 07/07/2011 | US20110165081 Psma antibodies and uses thereof |
| 07/07/2011 | US20110165079 Peptide for transmigration across blood brain barrier and delivery systems comprising the same |
| 07/07/2011 | US20110165073 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 07/07/2011 | US20110165068 Liposome medicament, method of preparation and use thereof |
| 07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | CA2786280A1 Methods for the prevention or treatment of vessel occlusion injury |
| 07/07/2011 | CA2786090A1 Interferon analogs |
| 07/07/2011 | CA2786066A1 Methods for performing a coronary artery bypass graft procedure |
| 07/07/2011 | CA2785633A1 Topical acyl glutathione formulations |
| 07/07/2011 | CA2785599A1 Purified bowman-birk protease inhibitor proteins isolated from a soy processing stream |
| 07/07/2011 | CA2784394A1 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof |
| 07/07/2011 | CA2784132A1 Composition for improving brain function and method for improving brain function |
| 07/06/2011 | EP2341348A1 Methods for detecting cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 07/06/2011 | EP2341148A2 Diagnosis and treatment of cancer |
| 07/06/2011 | EP2341144A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses |
| 07/06/2011 | EP2341143A1 OX2 receptor homolog |
| 07/06/2011 | EP2341142A2 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising same |
| 07/06/2011 | EP2341141A2 Recombinant platelet collagen receptor glycoprotein VI , antibodies and their pharmaceutical use |
| 07/06/2011 | EP2341138A1 FUSION PROTEIN COMPOSED OF MATRIX METALLOPROTEINASE-2 INHIBITOR PEPTIDE DERIVED FROM AMYLOID-beta PRECURSOR PROTEIN AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2341075A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341074A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2341067A1 Specific binding agents to hepatocyte growth factor |
| 07/06/2011 | EP2341066A1 Peptide having anti-diabetic activity and use thereof |
| 07/06/2011 | EP2341065A2 Inhibitors of serine proteases, particularly HCV NS3-NS4a protease |
| 07/06/2011 | EP2341063A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341062A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
| 07/06/2011 | EP2340856A1 Cosmetic or dermatologic formulation comprising a nutrient medium phase |
| 07/06/2011 | EP2340846A1 Caspofungin formulations |
| 07/06/2011 | EP2340845A2 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/06/2011 | EP2340843A1 Methods and compositions to treat myocardial conditions |
| 07/06/2011 | EP2340831A1 HT0712 for the treatment of a cognitive deficit |
| 07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
| 07/06/2011 | EP2340826A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders |
| 07/06/2011 | EP2340825A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using a neurotransmitter precursor |
| 07/06/2011 | EP2340725A1 Methods for the use of branched chain amino acids |
| 07/06/2011 | EP2340261A1 Amylin derivatives |
| 07/06/2011 | EP2340259A2 Novel toxin-antitoxin system |
| 07/06/2011 | EP2340258A2 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes |
| 07/06/2011 | EP2340040A2 Modulation of axon degeneration |
| 07/06/2011 | EP2340035A1 Treatment of fructose malabsorption |
| 07/06/2011 | EP2340034A2 Radioprotectants targeting thrombospondin-1 and cd47 |
| 07/06/2011 | EP2340033A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 07/06/2011 | EP2340032A2 Pharmaceutical composition for preventing or treating chronic obstructive pulmonary disease |
| 07/06/2011 | EP2340031A1 Use of gdf traps to increase red blood cell levels |
| 07/06/2011 | EP2340030A2 Methods, systems, and compositions for calpain inhibition |
| 07/06/2011 | EP2340029A2 Macrocyclic hepatitis c serine protease inhibitors |
| 07/06/2011 | EP2340028A1 Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors |
| 07/06/2011 | EP1919435B1 Dental composition comprising enzyme |
| 07/06/2011 | EP1891107B1 Compositions and methods for modulating immune responses |
| 07/06/2011 | EP1763362B1 Use of op-1 for treating cartilage defects |
| 07/06/2011 | EP1696897B1 Compositions for treating diabetes |